[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100568102":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":45,"collaborators":48,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":20,"enrollmentInfo":61,"targetDuration":20,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":29,"whyStopped":20,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Sentinel, primary palliative care intervention","EXPERIMENTAL","All participants will receive Sentinel, a primary palliative care intervention, in this single-arm feasibility trial. Participants will complete patient-reported assessments at the following time points:\n\n* Baseline (prior to HCT admission)\n* Week-2 of HCT hospitalization (+\u002F- 3 business days)\n* 1 month post-HCT (+\u002F- 7 business days)\n* 3 months post-HCT (+\u002F- 7 business days)",[13],"Behavioral: Primary palliative care",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BEHAVIORAL","Primary palliative care","Enrolled patient participants will receive Sentinel prior to and during their hospitalization for HCT. Prior to HCT, a transplant clinician (nurse practitioner - NP) will conduct a focused PC visit to build rapport, manage expectations regarding HCT, review anticipated symptoms, and discuss illness coping strategies. During the HCT hospitalization, HCT physicians and advanced practice providers will incorporate PC domains into their routine care of patients undergoing HCT.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Richard A Newcomb, MD","CONTACT","617-996-7584","richard.newcomb@mgh.harvard.edu",[28],{"facility":5,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"RECRUITING","Boston","Massachusetts","02152","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-71.05977,42.35843,{"lat":39,"lon":38},[42,43],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"name":23,"role":44,"phone":20,"phoneExt":20,"email":20},"PRINCIPAL_INVESTIGATOR",{"type":44,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Richard Andrew Newcomb, MD","Principal Investigator",[49],{"name":50,"class":51},"American Society of Transplantation and Cellular Therapy","UNKNOWN","100568102","feasibility-and-acceptability-of-primary-palliative-care-intervention-in-patients-undergoing-hematopoietic-stem-cell-transplantation-100568102",false,"NCT06676852","Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation","Primary PC HCT","Inclusion Criteria:\n\n* Age 18 years or older\n* Undergoing autologous or allogeneic HCT at MGH\n\nExclusion Criteria:\n\n* Prior receipt of inpatient specialty palliative care on two prior admissions in the past 6 months.\n* Significant uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the primary oncologist believes prohibits informed consent or ability to participate in study procedures\n* Inability to comprehend English as this is a preliminary\u002Fpilot study","ALL","18 Years",{"count":62,"type":63},40,"ESTIMATED","INTERVENTIONAL",[66],"NA","Primary PC - or training HCT clinicians to deliver PC domains as part of routine practice - is an alternative model of supportive care. We have developed Sentinel, a primary PC intervention for HCT clinicians and patients. This study will assess Sentinel's feasibility and acceptability.",[69,70],"Hematopoietic Cell Transplant","Hematologic Malignancy",[72,73,74,75],"palliative care","supportive care","primary palliative care","hematopoietic cell transplantation","2026-04-21",{"date":78,"type":79},"2026-04-24","ACTUAL",{"date":81,"type":79},"2026-01-05",{"date":83,"type":63},"2027-03-30",{"name":5,"class":6},1]